Emmy Graber, Hilary E Baldwin, Richard G Fried, Evan A Rieder, Adelaide A Hebert, James Del Rosso, Leon Kircik, Linda Stein Gold, Julie C Harper, Andrew F Alexis, Siva Narayanan, Volker Koscielny, Ismail Kasujee
BACKGROUND: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients’ functioning and activities of daily living (ADL) are needed. METHODS: A 12-week, single-arm, prospective cohort study was conducted in patients ≥9 years old with moderate/severe non-nodular facial AV prescribed sarecycline as part of usual care. The primary endpoint included AV-specific patient- and caregiver-reported outcomes assessed with the expert panel questionnaire (EPQ, developed by 10 experts using a Delphi method) in patients (>12 years) and caregivers (for patients 9-11 years)...
February 1, 2024: Journal of Drugs in Dermatology: JDD